BlueCrest Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-3,377
| Closed | -$296K | – | 833 |
|
|
2018
Q3 | $296K | Buy |
+3,377
| New | +$296K | 0.01% | 1030 |
|
|
2018
Q1 | – | Sell |
-4,529
| Closed | -$575K | – | 1439 |
|
|
2017
Q4 | $575K | Sell |
4,529
-11,426
| -72% | -$1.45M | 0.02% | 488 |
|
|
2017
Q3 | $1.88M | Sell |
15,955
-392
| -2% | -$46.1K | 0.08% | 249 |
|
|
2017
Q2 | $1.3M | Buy |
+16,347
| New | +$1.3M | 0.05% | 400 |
|
|
2016
Q1 | – | Sell |
-4,460
| Closed | -$420K | – | 699 |
|
|
2015
Q4 | $420K | Buy |
+4,460
| New | +$420K | 0.02% | 597 |
|